Showing results (131-140 of 538) with videos related to
Sort By:
Pageof 54
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Prognostic value of body mass index in locally advanced breast cancerShaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, et al.Journal of Cancer|May 7, 2014
Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cellsWendy A Woodward, Savitri Krishnamurthy, Ashutosh Lodhi, et al.Biomed Research International|June 16, 2015
Hereditary ovarian cancer: not only BRCA 1 and 2 genesAngela Toss, Chiara Tomasello, Elisabetta Razzaboni, et al.Cancer Research|January 24, 2018
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell ExpansionXuanmao Jiao, Marco A Velasco-Velázquez, Min Wang, et al.Breast Cancer Research and Treatment|May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.Cancer|May 23, 2012
The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversyShaheenah Dawood, Asim Jamal Shaikh, Thomas A Buchholz, et al.International Journal of Clinical Oncology|January 7, 2011
Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case seriesNaoki Hayashi, Seigo Nakamura, Hiroshi Yagata, et al.Clinical Breast Cancer|March 17, 2004
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experienceMassimo Cristofanilli, Ana Maria Gonzalez-Angulo, Aman U Buzdar, et al.Clinical Breast Cancer|October 3, 2013
A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populationsAkina Natori, Naoki Hayashi, Kumiko Soejima, et al.Journal of Experimental Therapeutics & Oncology|February 21, 2009
Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cellsFredika M Robertson, Ann-Marie Simeone, Abhijit Mazumdar, et al.Pageof 54